Prognostic value of systemic inflammatory markers in first- and subsequent-line immunotherapy and durability of response in NSCLC. Outcomes and safety analysis of a phase IB trial of stereotactic body ...
Residual of circulating tumor DNA (ctDNA) indicated therapeutic efficacy of sintilimab plus docetaxel in patients with previously treated advanced non-small cell lung cancer (NSCLC). Overweight or ...
Understanding the genotype–phenotype relationship of a cell has been a long-standing goal in biology. The availability of genome sequencing and of other high-throughput 'omic' data sets provides an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback